Journal Summary - Discover more summaries and articles from M3 India

Journal Summaries

Oncology

Choose Topic

A model to predict the feasibility of concurrent chemoradiotherapy with temozolomide in glioblastoma multiforme patients over age 65

American Journal of Clinical Oncology | Oct 21, 2017 Neurologic Oncology Pharmacology/Therapy General Oncology

Cabozantinib as salvage therapy for patients with tyrosine kinase inhibitorârefractory differentiated thyroid cancer: results of a multicenter phase ii international thyroid oncology group trial

Journal of Clinical Oncology | Oct 20, 2017 Endocrine Oncology General Oncology

NCCTG N0879 (Alliance): A randomized phase 2 cooperative group trial of carboplatin, paclitaxel, and bevacizumab Â± everolimus for metastatic melanoma

Cancer | Oct 20, 2017 Pharmacology/Therapy General Oncology Dermatologic Oncology

Cardiac safety of non-anthracycline trastuzumab-based therapy for HER2-positive breast cancer

Breast Cancer Research and Treatment | Oct 20, 2017 General Oncology Breast Pharmacology/Therapy

Fatty liver decreases the risk of liver metastasis in patients with breast cancer: A two-center cohort study

Breast Cancer Research and Treatment | Oct 20, 2017 General Oncology Breast

Size and location are the most important risk factors for malignant behavior in resected solitary fibrous tumors

Annals of Surgical Oncology | Oct 20, 2017 General Oncology Soft Tissue/Sarcoma

Determination of the impact of melanoma surgical timing on survival using the National Cancer Database

Journal of the American Academy of Dermatology | Oct 20, 2017 Dermatologic Oncology General Oncology

The association between high birth weight and the risks of childhood CNS tumors and leukemia: An analysis of a US case-control study in an epidemiological database

BMC Cancer | Oct 20, 2017 Neurologic Oncology General Oncology Peds Heme/Oncology Leukemia/Lymphoma

A single-arm phase II study of nab-paclitaxel for patients with chemorefractory non-small cell lung cancer

BMC Cancer | Oct 20, 2017 General Oncology Lung/Thoracic Oncology Pharmacology/Therapy

Randomized study of etirinotecan pegol versus irinotecan as second-line treatment for metastatic colorectal cancer

Cancer Chemotherapy and Pharmacology | Oct 20, 2017 Colorectal Cancer/Polyps General Oncology

« Prev 1 … 1151 1152 1153 1154 1155 … 1255 Next »

A model to predict the feasibility of concurrent chemoradiotherapy with temozolomide in glioblastoma multiforme patients over age 65

Cabozantinib as salvage therapy for patients with tyrosine kinase inhibitorârefractory differentiated thyroid cancer: results of a multicenter phase ii international thyroid oncology group trial

NCCTG N0879 (Alliance): A randomized phase 2 cooperative group trial of carboplatin, paclitaxel, and bevacizumab Â± everolimus for metastatic melanoma

Cardiac safety of non-anthracycline trastuzumab-based therapy for HER2-positive breast cancer

Fatty liver decreases the risk of liver metastasis in patients with breast cancer: A two-center cohort study

Size and location are the most important risk factors for malignant behavior in resected solitary fibrous tumors

Determination of the impact of melanoma surgical timing on survival using the National Cancer Database

The association between high birth weight and the risks of childhood CNS tumors and leukemia: An analysis of a US case-control study in an epidemiological database

A single-arm phase II study of nab-paclitaxel for patients with chemorefractory non-small cell lung cancer

Randomized study of etirinotecan pegol versus irinotecan as second-line treatment for metastatic colorectal cancer

Awareness for COPD: MCQ challenge

BRI or BMI: What is More Efficient?

Gut Health Disorders and its Management

How 2 Common Sleep Habits Increase Your Risk of Death

The Role of Exercise and Movement Therapy in Enhancing Recovery from Chronic Conditions

A model to predict the feasibility of concurrent chemoradiotherapy with temozolomide in glioblastoma multiforme patients over age 65

Cabozantinib as salvage therapy for patients with tyrosine kinase inhibitorârefractory differentiated thyroid cancer: results of a multicenter phase ii international thyroid oncology group trial

NCCTG N0879 (Alliance): A randomized phase 2 cooperative group trial of carboplatin, paclitaxel, and bevacizumab Â± everolimus for metastatic melanoma

Cardiac safety of non-anthracycline trastuzumab-based therapy for HER2-positive breast cancer

Fatty liver decreases the risk of liver metastasis in patients with breast cancer: A two-center cohort study

Size and location are the most important risk factors for malignant behavior in resected solitary fibrous tumors

Determination of the impact of melanoma surgical timing on survival using the National Cancer Database

The association between high birth weight and the risks of childhood CNS tumors and leukemia: An analysis of a US case-control study in an epidemiological database

A single-arm phase II study of nab-paclitaxel for patients with chemorefractory non-small cell lung cancer

Randomized study of etirinotecan pegol versus irinotecan as second-line treatment for metastatic colorectal cancer

Awareness for COPD: MCQ challenge

BRI or BMI: What is More Efficient?

Gut Health Disorders and its Management

How 2 Common Sleep Habits Increase Your Risk of Death

The Role of Exercise and Movement Therapy in Enhancing Recovery from Chronic Conditions

Select Specialty

Select Topic

Cabozantinib as salvage therapy for patients with tyrosine kinase inhibitorârefractory differentiated thyroid cancer: results of a multicenter phase ii international thyroid oncology group trial